| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Constantin A Hintschich, Veronika Vielsmeier, Christopher Bohr, Jan Hagemann, Ludger Klime. Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2-results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2). European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2022-06-29. PMID:35767061. |
here, we report on a prospective study to psychophysically compare olfactory function in acute sars-cov-2 infection between wild type, voc alpha and voc delta. |
2022-06-29 |
2023-08-14 |
Not clear |
| Shohei Inui, Akira Fujikawa, Wataru Gonoi, Shuichi Kawano, Keita Sakurai, Yuto Uchida, Masanori Ishida, Osamu Ab. Comparison of CT findings of coronavirus disease 2019 (COVID-19) pneumonia caused by different major variants. Japanese journal of radiology. 2022-06-28. PMID:35763239. |
to explore the ct findings and pneumonnia progression pattern of the alpha and delta variants of sars-cov-2 by comparing them with the pre-existing wild type. |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
covid-19 due to the b.1.617.2 (delta) variant compared to b.1.1.7 (alpha) variant of sars-cov-2: a prospective observational cohort study. |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
this prospective observational cohort study assessed symptomatic adults participating in the app-based covid symptom study who tested positive for sars-cov-2 from may 26 to july 1, 2021 (delta overwhelmingly the predominant circulating uk variant), compared (1:1, age- and sex-matched) with individuals presenting from december 28, 2020 to may 6, 2021 (alpha (b.1.1.7) the predominant variant). |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
within the first 28 days of illness, some symptoms were more common with delta versus alpha infection (including fever, sore throat, and headache) and some vice versa (dyspnoea). |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
symptom burden in the first week was higher with delta versus alpha infection; however, the odds of any given symptom lasting ≥ 7 days was either lower or unchanged. |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
illness duration ≥ 28 days was lower with delta versus alpha infection, though unchanged in unvaccinated individuals. |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
the delta variant appeared more (1.49) transmissible than alpha. |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
we conclude that covid-19 from delta or alpha infections is similar. |
2022-06-28 |
2023-08-14 |
Not clear |
| Kerstin Kläser, Erika Molteni, Mark Graham, Liane S Canas, Marc F Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, Marc Modat, Alexander Hammers, Tim D Spector, Claire J Steves, Carole H Sudre, Sebastien Ourselin, Emma L Dunca. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Scientific reports. vol 12. issue 1. 2022-06-28. PMID:35764879. |
the delta variant is more transmissible than alpha; however, current vaccines showed good efficacy against disease. |
2022-06-28 |
2023-08-14 |
Not clear |
| Abdelmajeed Nasereddin, Hadar Golan Berman, Dana G Wolf, Esther Oiknine-Djian, Sheera Ada. Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing. Microbiology spectrum. 2022-06-27. PMID:35758686. |
two samples were mixtures of two variants, one of alpha and beta and one of alpha and delta. |
2022-06-27 |
2023-08-14 |
Not clear |
| Houriiyah Tegally, Monika Moir, Josie Everatt, Marta Giovanetti, Cathrine Scheepers, Eduan Wilkinson, Kathleen Subramoney, Zinhle Makatini, Sikhulile Moyo, Daniel G Amoako, Cheryl Baxter, Christian L Althaus, Ugochukwu J Anyaneji, Dikeledi Kekana, Raquel Viana, Jennifer Giandhari, Richard J Lessells, Tongai Maponga, Dorcas Maruapula, Wonderful Choga, Mogomotsi Matshaba, Mpaphi B Mbulawa, Nokukhanya Msomi, Yeshnee Naidoo, Sureshnee Pillay, Tomasz Janusz Sanko, James E San, Lesley Scott, Lavanya Singh, Nonkululeko A Magini, Pamela Smith-Lawrence, Wendy Stevens, Graeme Dor, Derek Tshiabuila, Nicole Wolter, Wolfgang Preiser, Florette K Treurnicht, Marietjie Venter, Georginah Chiloane, Caitlyn McIntyre, Aine O'Toole, Christopher Ruis, Thomas P Peacock, Cornelius Roemer, Sergei L Kosakovsky Pond, Carolyn Williamson, Oliver G Pybus, Jinal N Bhiman, Allison Glass, Darren P Martin, Ben Jackson, Andrew Rambaut, Oluwakemi Laguda-Akingba, Simani Gaseitsiwe, Anne von Gottberg, Tulio de Oliveir. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nature medicine. 2022-06-27. PMID:35760080. |
the spike proteins of ba.4 and ba.5 are identical, and comparable to ba.2 except for the addition of 69-70del (present in the alpha variant and the ba.1 lineage), l452r (present in the delta variant), f486v and the wild type amino acid at q493.the two lineages only differ outside of the spike region. |
2022-06-27 |
2023-08-14 |
human |
| Massab Umair, Aamer Ikram, Zaira Rehman, Syed Adnan Haider, Muhammad Ammar, Nazish Badar, Qasim Ali, Muhammad Suleman Rana, Muhammad Salma. Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic. Journal of medical virology. 2022-06-26. PMID:35754094. |
the results showed that 97% (n=136) of isolates belonged to delta variant while three isolates belonged to alpha and only one isolate belonged to beta variant. |
2022-06-26 |
2023-08-14 |
Not clear |
| Povilas Tarailis, Frances M De Blasio, Dovile Simkute, Inga Griskova-Bulanov. Data-Driven EEG Theta and Alpha Components Are Associated with Subjective Experience during Resting State. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743681. |
five minutes of resting multichannel eeg was recorded in 226 participants and six eeg data-driven components were extracted-three components in the alpha range (peaking at 9, 10.5, and 11.5 hz) and one each in the delta (peaking at 0.5 hz), theta (peaking at 5.5 hz) and beta (peaking at 17 hz) ranges. |
2022-06-24 |
2023-08-14 |
human |
| Vincenza Granata, Roberta Fusco, Alberta Villanacci, Simona Magliocchetti, Fabrizio Urraro, Nardi Tetaj, Luisa Marchioni, Fabrizio Albarello, Paolo Campioni, Massimo Cristofaro, Federica Di Stefano, Nicoletta Fusco, Ada Petrone, Vincenzo Schininà, Francesca Grassi, Enrico Girardi, Stefania Ianniell. Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center. Journal of personalized medicine. vol 12. issue 6. 2022-06-24. PMID:35743740. |
to analyze the vaccine effect by comparing five groups: unvaccinated patients with alpha variant, unvaccinated patients with delta variant, vaccinated patients with delta variant, unvaccinated patients with omicron variant, and vaccinated patients with omicron variant, assessing the "gravity" of covid-19 pulmonary involvement, based on ct findings in critically ill patients admitted to intensive care unit (icu). |
2022-06-24 |
2023-08-14 |
Not clear |
| Floriana Bonura, Dario Genovese, Emanuele Amodio, Giuseppe Calamusa, Giuseppa Luisa Sanfilippo, Federica Cacioppo, Giovanni Maurizio Giammanco, Simona De Grazia, Donatella Ferrar. Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination. Vaccines. vol 10. issue 6. 2022-06-24. PMID:35746482. |
significantly higher ntab titers were found against b.1 and alpha in both covid-19+ and vaccinees, while lower ntab titers were detected against delta, gamma, and omicron variants. |
2022-06-24 |
2023-08-14 |
human |
| Janhavi Prasad Natekar, Heather Pathak, Shannon Stone, Pratima Kumari, Shaligram Sharma, Tabassum Tasnim Auroni, Komal Arora, Hussin Alwan Rothan, Mukesh Kuma. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice. Viruses. vol 14. issue 6. 2022-06-24. PMID:35746611. |
eight-week-old k18-hace2 mice were inoculated intranasally with a representative virus from the original b.1 lineage or from the emerging b.1.1.7 (alpha), b.1.351 (beta), b.1.617.2 (delta), or b.1.1.529 (omicron) lineages. |
2022-06-24 |
2023-08-14 |
mouse |
| Roberta Rizzo, Daria Bortolotti, Luca Morandi, Sabrina Rizzo, Giovanna Schiuma, Silvia Beltrami, Alberto Papi, Marco Contol. Humoral and adaptive immune responses to SARS-CoV-2 vaccine. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2022-06-24. PMID:35750264. |
to assess the relevance of serum levels of sars-cov-2 specific antibodies and to further characterize the immune response to sars-cov-2 vaccines, we report: i) the levels of spike-binding and neutralizing antibodies to sars-cov-2 in sera of thirty healthy volunteers at 9 months after the second vaccination dose of mrna-vaccines and 1-month after the booster dose; ii) the levels of ifn-γ (interferon-γ) production by blood t-cells exposed to sars-cov-2 spike antigen (wuhan, alpha b.1.1.7, delta b.1.617.2, omicron b1.1.529 variants); and iii) the specific phenotype of t-cells related with exposure to sars-cov-2 spike antigen. |
2022-06-24 |
2023-08-14 |
human |
| Kefan Yang, Daniel N Schuder, Arlene K Ngor, John C Chapu. REVEALR-Based Genotyping of SARS-CoV-2 Variants of Concern in Clinical Samples. Journal of the American Chemical Society. 2022-06-22. PMID:35729726. |
of 34 sequence-verified patient samples collected in early, mid, and late 2021 at the uci medical center in orange, california, revealr identified the correct variant [wuhan-hu-1, alpha (b.1.1.7), gamma (p.1), epsilon (b.1.427/9), delta (b.1.617.2), and omicron (b.1.1.529)] with 100% accuracy. |
2022-06-22 |
2023-08-14 |
Not clear |
| Ayman Al Jurdi, Leela Morena, Mariesa Cote, Emily Bethea, Jamil Azzi, Leonardo V Riell. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the Omicron wave. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2022-06-21. PMID:35727916. |
the neutralizing monoclonal antibody combination of tixagevimab/cilgavimab has been shown to reduce the risk of sars-cov-2 infection in unvaccinated individuals during the alpha (b.1.1.7) and delta (b.1.617.2) waves. |
2022-06-21 |
2023-08-14 |
Not clear |